ZTS

About Zoetis Inc.

Zoetis Inc. (NYSE: ZTS) is a Healthcare company (Drug Manufacturers - Specialty & Generic) with a market capitalization of $32.9B. Its Maz Rating is 3.23 out of 5 (B+, Buy), ranked against the other companies in its sector.

Factor scores: Valuation 2.95, Growth 2.42, Profitability 4.98, Financial Health 3.03, Momentum 2.69 (as of 2026-10-16).

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
US
CEO
Kristin C. Peck
Employees
14,500
IPO date
2013-02-01